Delta 9 Cannabis Inc said it expects to announce revenue of between $12.4 million and $12.6 million for the three months ended March 31, 2022 compared to $13.2 million in the year-ago period when it reports its first quarter results before the market opens on Monday.
However, the revenue estimates are preliminary and subject to the completion of Delta 9’s financial closing procedures, the company said, noting that the actual results could differ materially.
Delta 9 is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses.
READ: Delta 9 Cannabis announces opening of thirty-fifth cannabis retail store; launches Canada's first mobile cannabis store
The company will hold a conference call hosted by CEO John Arbuthnot to discuss the results at noon ET on Monday, which will include a question and answer session. Interested parties can dial in at 1-888-886-7786, the company said.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel